Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Nigeria rolls out new 5-in-1 vaccine against meningitis

Ruchika Sharma15 April 2024 12:36 PM IST

This new multivalent conjugate vaccine was 13 years in the making and was based on a partnership between PATH and the Serum Institute of India.

Bayer AG arm AskBio names Mansuo Shannon as Chief Scientific Officer

Ruchika Sharma14 April 2024 1:00 PM IST

Research Triangle Park: Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, has...

Novartis declares positive results from phase III study for new malaria treatment

Arvinas, Novartis collaborate for development, commercialization of ARV-766 for prostate cancer

Ruchika Sharma14 April 2024 10:00 AM IST

New Haven: Arvinas, Inc., a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, has...

Johnson and Johnson Agrees to Cut US Drug Prices in Deal with Trump Administration to Avoid Tariffs

Kenya drug regulator recalls a batch of JnJ children cough syrup

Ruchika Sharma13 April 2024 4:15 PM IST

Nairobi: Kenya's drug regulator said on thursday it is recalling a batch of Johnson & Johnson children's cough syrup, following...

USFDA Grants Tentative Approval, 180-Day Exclusivity to Granules Generic Amphetamine XR

Granules India gets Zero 483's from USFDA for Unit V facility in AP

Ruchika Sharma13 April 2024 12:08 PM IST

Telangana: Granules India has informed in a BSE filing that the Company's Unit V facility located at Anakapally, Visakhapatnam, Andhra ...

Granules India packaging facility in US successfully completes USFDA inspection

USFDA concludes inspection of Lupin Dabhasa facility with no observations

Ruchika Sharma13 April 2024 11:48 AM IST

Mumbai: Global pharma major Lupin Limited has announced that the United States Food and Drug Administration (U.S. FDA) has completed a GMP...

Novartis concludes acquisition of Tourmaline Bio

Novartis tender offer for MorphoSys AG commences

Ruchika Sharma12 April 2024 3:30 PM IST

Basel: Novartis has published the offer document for the voluntary public takeover offer by its wholly owned subsidiary Novartis BidCo AG for all...

SII partners with Univercells to bring affordable personalized oncology to masses

Ruchika Sharma12 April 2024 2:38 PM IST

Pune: In a landmark collaboration announced, Serum Institute of India (SII), the world's largest vaccine manufacturer, has joined forces with...

Roche Lunsumio VELO bags USFDA approval for subcutaneous use in follicular lymphoma

Roche gets CE Mark for companion diagnostic to identify patients with HER2-low metastatic breast cancer eligible for Enhertu

Ruchika Sharma12 April 2024 12:54 PM IST

Tucson: Roche has announced the approval of the CE Mark for the VENTANA HER2 (4B5) Rabbit Monoclonal Primary Antibody RxDx to identify...

Revise Phase III Trial Protocol for Roflumilast Cream: CDSCO Panel Tells Sun Pharma

Sun Pharma receives OAI status from USFDA for Dadra facility

Ruchika Sharma12 April 2024 11:42 AM IST

Mumbai: Sun Pharma has informed in a BSE filing that the US Food and Drug Administration (USFDA) has determined the inspection classification...

Palamur Biosciences Faces USFDA Warning for Multiple GLP Compliance Failures

Roche gets USFDA Breakthrough Device Designation for blood test to support earlier Alzheimer's disease diagnosis

Ruchika Sharma11 April 2024 5:47 PM IST

Basel: Roche has announced that its Elecsys pTau217 assay has received Breakthrough Device Designation from the U.S. Food and Drug Administration...

Sun Pharma unit Taro recalls over 17k units of antifungal medication in US

Glenmark, Lupin and 1 other recall products in US over manufacturing issues

Ruchika Sharma11 April 2024 3:02 PM IST

New Delhi: Glenmark, Lupin, and Natco Pharma, key players in the generic drug industry, are recalling products in the American market due to...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok